Hymenialdisine or derivatives thereof in the manufacture of medicaments
US7098204B2 · kind B2 · utility
4Cited by
7References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 7, 2000 |
| Grant date | Aug 29, 2006 |
| Priority date | — |
| Expiry date | Dec 7, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of hymenialdisine or derivatives thereof of formula (I) in which R1 and R2, identical or different, represent H or Br, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in inhibiting acceptable salt thereof, in the manufacture of a medicament for use in inhibiting cycline dependent kineases, GSK-3β and casein kinase 1. Application for preventing and treating neurodegenerative disorders, diabetes, inflammatory pathologies and cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.